TITLE:
Assessment of Potential Interactions Between Methamphetamine and Selegiline - 1

CONDITION:
Amphetamine-Related Disorders

INTERVENTION:
Selegiline

SUMMARY:

      The purpose of this study is to assess the potential interactions between intravenous
      methamphetamine and oral selegiline.
    

DETAILED DESCRIPTION:

      To determine the safety of the selegiline concurrent with d-methamphetamine challenges of
      15mg & 30mg i.v. with the focus being on cardiovascular responses (HR,BP) to the i.v.
      methamphetamine challenges. This is a randomized, single-blind, placebo-controlled, two-arm
      study design to evaluate the safety of selegiline treatment, compared to placebo treatment,
      concurrent with i.v. methamphetamine challenges.
    

ELIGIBILITY:
Gender: All
Age: 18 Years to 45 Years
Criteria:

        Inclusion Criteria:

          -  Volunteers who meet DSM-4 criteria for methamphetamine abuse or dependence;
             non-treatment seeking individuals

          -  Be able to verbalize understanding of consent form; provide written informed consent

        Exclusion Criteria:

          -  Please contact site for more information
      
